CooperSurgical, a subsidiary of $2.4b producer of women’s health devices and contact lenses, CooperCompanies (NYSE: COO) has bought AEGEA Medical, a developer of an office-based Water Vapor Ablation System treating heavy menstrual bleeding. The system, Mara, takes two-minutes to perform and ablates the lining of the uterus, the source of heavy menstrual bleeding in premenopausal women. 99% of patients reported improvement in quality of life from the procedure in a key clinical study. AEGEA was backed by lifescience venture capitalist Solas BioVentures. Terms not announced.
Keywords: Healthcare Investment Banking, Healthcare M&A, Healthcare Mergers, Medical Devices